| UniProt ID | VDAC2_HUMAN | |
|---|---|---|
| UniProt AC | P45880 | |
| Protein Name | Voltage-dependent anion-selective channel protein 2 | |
| Gene Name | VDAC2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 294 | |
| Subcellular Localization | Mitochondrion outer membrane . | |
| Protein Description | Forms a channel through the mitochondrial outer membrane that allows diffusion of small hydrophilic molecules. The channel adopts an open conformation at low or zero membrane potential and a closed conformation at potentials above 30-40 mV. The open state has a weak anion selectivity whereas the closed state is cation-selective.. | |
| Protein Sequence | MATHGQTCARPMCIPPSYADLGKAARDIFNKGFGFGLVKLDVKTKSCSGVEFSTSGSSNTDTGKVTGTLETKYKWCEYGLTFTEKWNTDNTLGTEIAIEDQICQGLKLTFDTTFSPNTGKKSGKIKSSYKRECINLGCDVDFDFAGPAIHGSAVFGYEGWLAGYQMTFDSAKSKLTRNNFAVGYRTGDFQLHTNVNDGTEFGGSIYQKVCEDLDTSVNLAWTSGTNCTRFGIAAKYQLDPTASISAKVNNSSLIGVGYTQTLRPGVKLTLSALVDGKSINAGGHKVGLALELEA | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MATHGQTCA ------CCCCCCCCC | 14.33 | 25944712 | |
| 2 (in isoform 1) | Phosphorylation | - | 14.33 | 27135362 | |
| 7 | Phosphorylation | -MATHGQTCARPMCI -CCCCCCCCCCCCCC | 16.84 | - | |
| 17 | Phosphorylation | RPMCIPPSYADLGKA CCCCCCCCHHHHHHH | 27.83 | 24043423 | |
| 18 | Phosphorylation | PMCIPPSYADLGKAA CCCCCCCHHHHHHHH | 15.20 | 24043423 | |
| 20 (in isoform 2) | Ubiquitination | - | 47.96 | 21890473 | |
| 28 (in isoform 2) | Ubiquitination | - | 3.23 | 21890473 | |
| 31 | Acetylation | AARDIFNKGFGFGLV HHHHHHHCCCCCEEE | 44.88 | 19608861 | |
| 31 | Succinylation | AARDIFNKGFGFGLV HHHHHHHCCCCCEEE | 44.88 | - | |
| 31 | Ubiquitination | AARDIFNKGFGFGLV HHHHHHHCCCCCEEE | 44.88 | 25621951 | |
| 31 | Succinylation | AARDIFNKGFGFGLV HHHHHHHCCCCCEEE | 44.88 | 23954790 | |
| 31 (in isoform 3) | Ubiquitination | - | 44.88 | 21890473 | |
| 39 | Acetylation | GFGFGLVKLDVKTKS CCCCEEEEEEECCCC | 43.97 | 23954790 | |
| 39 | Ubiquitination | GFGFGLVKLDVKTKS CCCCEEEEEEECCCC | 43.97 | 21890473 | |
| 39 (in isoform 3) | Ubiquitination | - | 43.97 | 21890473 | |
| 44 | Phosphorylation | LVKLDVKTKSCSGVE EEEEEECCCCCCCCE | 28.21 | 30108239 | |
| 45 | 2-Hydroxyisobutyrylation | VKLDVKTKSCSGVEF EEEEECCCCCCCCEE | 43.69 | - | |
| 45 | Acetylation | VKLDVKTKSCSGVEF EEEEECCCCCCCCEE | 43.69 | 26051181 | |
| 46 | Phosphorylation | KLDVKTKSCSGVEFS EEEECCCCCCCCEEE | 20.81 | 25159151 | |
| 46 (in isoform 1) | Ubiquitination | - | 20.81 | 21890473 | |
| 46 | Acetylation | KLDVKTKSCSGVEFS EEEECCCCCCCCEEE | 20.81 | 19608861 | |
| 46 | Ubiquitination | KLDVKTKSCSGVEFS EEEECCCCCCCCEEE | 20.81 | 19608861 | |
| 47 | S-nitrosocysteine | LDVKTKSCSGVEFST EEECCCCCCCCEEEC | 4.35 | - | |
| 47 | S-nitrosylation | LDVKTKSCSGVEFST EEECCCCCCCCEEEC | 4.35 | 22178444 | |
| 48 | Phosphorylation | DVKTKSCSGVEFSTS EECCCCCCCCEEECC | 53.62 | 30108239 | |
| 53 | Phosphorylation | SCSGVEFSTSGSSNT CCCCCEEECCCCCCC | 14.25 | 30108239 | |
| 54 | Phosphorylation | CSGVEFSTSGSSNTD CCCCEEECCCCCCCC | 42.29 | 30108239 | |
| 54 (in isoform 1) | Ubiquitination | - | 42.29 | 21890473 | |
| 54 | Acetylation | CSGVEFSTSGSSNTD CCCCEEECCCCCCCC | 42.29 | 19608861 | |
| 54 | Ubiquitination | CSGVEFSTSGSSNTD CCCCEEECCCCCCCC | 42.29 | 19608861 | |
| 55 | Phosphorylation | SGVEFSTSGSSNTDT CCCEEECCCCCCCCC | 35.16 | 30108239 | |
| 57 | Phosphorylation | VEFSTSGSSNTDTGK CEEECCCCCCCCCCE | 21.85 | 30576142 | |
| 58 | Phosphorylation | EFSTSGSSNTDTGKV EEECCCCCCCCCCEE | 47.47 | 30576142 | |
| 60 | Phosphorylation | STSGSSNTDTGKVTG ECCCCCCCCCCEEEE | 36.56 | 30576142 | |
| 61 (in isoform 1) | Phosphorylation | - | 58.68 | 27251275 | |
| 61 (in isoform 2) | Ubiquitination | - | 58.68 | 21890473 | |
| 62 | Phosphorylation | SGSSNTDTGKVTGTL CCCCCCCCCEEEEEE | 36.54 | 30576142 | |
| 64 | Acetylation | SSNTDTGKVTGTLET CCCCCCCEEEEEEEC | 38.42 | 26051181 | |
| 64 | Ubiquitination | SSNTDTGKVTGTLET CCCCCCCEEEEEEEC | 38.42 | 25621951 | |
| 66 | Phosphorylation | NTDTGKVTGTLETKY CCCCCEEEEEEECEE | 28.12 | 26657352 | |
| 68 | Phosphorylation | DTGKVTGTLETKYKW CCCEEEEEEECEEEE | 16.44 | 30576142 | |
| 71 | Phosphorylation | KVTGTLETKYKWCEY EEEEEEECEEEEECC | 42.67 | 23403867 | |
| 72 | Acetylation | VTGTLETKYKWCEYG EEEEEECEEEEECCC | 35.14 | 25825284 | |
| 72 | Ubiquitination | VTGTLETKYKWCEYG EEEEEECEEEEECCC | 35.14 | 21906983 | |
| 72 | 2-Hydroxyisobutyrylation | VTGTLETKYKWCEYG EEEEEECEEEEECCC | 35.14 | - | |
| 72 (in isoform 3) | Ubiquitination | - | 35.14 | 21890473 | |
| 73 | Phosphorylation | TGTLETKYKWCEYGL EEEEECEEEEECCCC | 19.69 | 24719451 | |
| 74 | Acetylation | GTLETKYKWCEYGLT EEEECEEEEECCCCE | 47.10 | 23954790 | |
| 74 | Ubiquitination | GTLETKYKWCEYGLT EEEECEEEEECCCCE | 47.10 | - | |
| 74 | 2-Hydroxyisobutyrylation | GTLETKYKWCEYGLT EEEECEEEEECCCCE | 47.10 | - | |
| 74 | Malonylation | GTLETKYKWCEYGLT EEEECEEEEECCCCE | 47.10 | 26320211 | |
| 76 | S-nitrosocysteine | LETKYKWCEYGLTFT EECEEEEECCCCEEE | 2.23 | - | |
| 76 | S-nitrosylation | LETKYKWCEYGLTFT EECEEEEECCCCEEE | 2.23 | 22178444 | |
| 78 | Phosphorylation | TKYKWCEYGLTFTEK CEEEEECCCCEEEEC | 17.82 | 20090780 | |
| 81 (in isoform 1) | Phosphorylation | - | 24.93 | 24719451 | |
| 81 | Phosphorylation | KWCEYGLTFTEKWNT EEECCCCEEEECCCC | 24.93 | 28857561 | |
| 83 (in isoform 1) | Phosphorylation | - | 31.27 | 24719451 | |
| 83 | Phosphorylation | CEYGLTFTEKWNTDN ECCCCEEEECCCCCC | 31.27 | 28102081 | |
| 87 (in isoform 1) | Ubiquitination | - | 48.93 | 21890473 | |
| 87 | Acetylation | LTFTEKWNTDNTLGT CEEEECCCCCCCCCC | 48.93 | 19608861 | |
| 87 | Ubiquitination | LTFTEKWNTDNTLGT CEEEECCCCCCCCCC | 48.93 | 19608861 | |
| 88 (in isoform 1) | Phosphorylation | - | 29.52 | 24719451 | |
| 89 | Acetylation | FTEKWNTDNTLGTEI EEECCCCCCCCCCEE | 42.79 | 19608861 | |
| 93 (in isoform 1) | Phosphorylation | - | 21.18 | 25147952 | |
| 109 | Phosphorylation | ICQGLKLTFDTTFSP HHCCCEEEEEEEECC | 20.20 | 26846344 | |
| 109 (in isoform 2) | Ubiquitination | - | 20.20 | 21890473 | |
| 112 | Phosphorylation | GLKLTFDTTFSPNTG CCEEEEEEEECCCCC | 26.08 | 30266825 | |
| 113 | Phosphorylation | LKLTFDTTFSPNTGK CEEEEEEEECCCCCC | 24.78 | 22167270 | |
| 115 | Phosphorylation | LTFDTTFSPNTGKKS EEEEEEECCCCCCCC | 18.36 | 19664994 | |
| 118 | Phosphorylation | DTTFSPNTGKKSGKI EEEECCCCCCCCCCC | 54.48 | 26846344 | |
| 120 | Acetylation | TFSPNTGKKSGKIKS EECCCCCCCCCCCCC | 41.55 | 25953088 | |
| 120 | Ubiquitination | TFSPNTGKKSGKIKS EECCCCCCCCCCCCC | 41.55 | 21906983 | |
| 120 | 2-Hydroxyisobutyrylation | TFSPNTGKKSGKIKS EECCCCCCCCCCCCC | 41.55 | - | |
| 120 | Malonylation | TFSPNTGKKSGKIKS EECCCCCCCCCCCCC | 41.55 | 26320211 | |
| 120 (in isoform 3) | Ubiquitination | - | 41.55 | 21890473 | |
| 121 | Ubiquitination | FSPNTGKKSGKIKSS ECCCCCCCCCCCCCC | 66.83 | 25621951 | |
| 124 | Ubiquitination | NTGKKSGKIKSSYKR CCCCCCCCCCCCCHH | 54.79 | 25621951 | |
| 128 | Phosphorylation | KSGKIKSSYKRECIN CCCCCCCCCHHHHHC | 29.67 | 20833797 | |
| 128 (in isoform 1) | Phosphorylation | - | 29.67 | 21406692 | |
| 130 (in isoform 1) | Phosphorylation | - | 43.60 | 24719451 | |
| 133 (in isoform 1) | Phosphorylation | - | 2.65 | 21406692 | |
| 135 (in isoform 1) | Ubiquitination | - | 41.88 | 21890473 | |
| 136 (in isoform 1) | Ubiquitination | - | 3.51 | - | |
| 184 | Phosphorylation | RNNFAVGYRTGDFQL CCCEEEEEECCCEEE | 9.82 | 23911959 | |
| 204 | Phosphorylation | DGTEFGGSIYQKVCE CCCCCCCHHHHHHHC | 20.64 | 28152594 | |
| 206 | Phosphorylation | TEFGGSIYQKVCEDL CCCCCHHHHHHHCCC | 12.18 | 28152594 | |
| 224 (in isoform 2) | Ubiquitination | - | 17.36 | 21890473 | |
| 235 | Acetylation | TRFGIAAKYQLDPTA CEEEEEEEEECCCCC | 25.22 | 25825284 | |
| 235 | Ubiquitination | TRFGIAAKYQLDPTA CEEEEEEEEECCCCC | 25.22 | 21906983 | |
| 235 (in isoform 3) | Ubiquitination | - | 25.22 | 21890473 | |
| 236 | Phosphorylation | RFGIAAKYQLDPTAS EEEEEEEEECCCCCE | 15.02 | 28152594 | |
| 243 | Phosphorylation | YQLDPTASISAKVNN EECCCCCEEEEEECC | 21.39 | 25627689 | |
| 245 | Phosphorylation | LDPTASISAKVNNSS CCCCCEEEEEECCCC | 21.39 | - | |
| 247 | Malonylation | PTASISAKVNNSSLI CCCEEEEEECCCCEE | 38.41 | 26320211 | |
| 247 | Acetylation | PTASISAKVNNSSLI CCCEEEEEECCCCEE | 38.41 | 26051181 | |
| 250 (in isoform 1) | Ubiquitination | - | 35.64 | 21890473 | |
| 251 | Phosphorylation | ISAKVNNSSLIGVGY EEEEECCCCEEEECC | 22.71 | 25159151 | |
| 251 | O-linked_Glycosylation | ISAKVNNSSLIGVGY EEEEECCCCEEEECC | 22.71 | 23301498 | |
| 252 | Phosphorylation | SAKVNNSSLIGVGYT EEEECCCCEEEECCC | 26.57 | 28152594 | |
| 258 | Phosphorylation | SSLIGVGYTQTLRPG CCEEEECCCCCCCCC | 8.02 | 28152594 | |
| 259 | Phosphorylation | SLIGVGYTQTLRPGV CEEEECCCCCCCCCC | 14.78 | 28152594 | |
| 259 | O-linked_Glycosylation | SLIGVGYTQTLRPGV CEEEECCCCCCCCCC | 14.78 | 23301498 | |
| 261 | Phosphorylation | IGVGYTQTLRPGVKL EEECCCCCCCCCCEE | 19.55 | 25849741 | |
| 262 (in isoform 1) | Ubiquitination | - | 4.47 | - | |
| 269 | Phosphorylation | LRPGVKLTLSALVDG CCCCCEEEEEEEECC | 16.98 | 21712546 | |
| 271 | Phosphorylation | PGVKLTLSALVDGKS CCCEEEEEEEECCEE | 17.83 | 21712546 | |
| 274 (in isoform 2) | Ubiquitination | - | 10.23 | 21890473 | |
| 277 | Acetylation | LSALVDGKSINAGGH EEEEECCEEECCCCC | 43.64 | 26051181 | |
| 277 | Ubiquitination | LSALVDGKSINAGGH EEEEECCEEECCCCC | 43.64 | 25621951 | |
| 278 | Phosphorylation | SALVDGKSINAGGHK EEEECCEEECCCCCE | 26.97 | 22210691 | |
| 285 | Ubiquitination | SINAGGHKVGLALEL EECCCCCEEEEEEEE | 41.07 | 21890473 | |
| 285 | Acetylation | SINAGGHKVGLALEL EECCCCCEEEEEEEE | 41.07 | 26051181 | |
| 285 (in isoform 3) | Ubiquitination | - | 41.07 | 21890473 | |
| 300 (in isoform 1) | Ubiquitination | - | 21890473 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 48 | S | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of VDAC2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of VDAC2_HUMAN !! | ||||||
| Kegg Disease | |
|---|---|
| There are no disease associations of PTM sites. | |
| OMIM Disease | |
| There are no disease associations of PTM sites. | |
| Kegg Drug | |
| There are no disease associations of PTM sites. | |
| DrugBank | |
| DB01375 | Dihydroxyaluminium |
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-115, AND MASS SPECTROMETRY. | |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-31; LYS-39; LYS-72 ANDLYS-74, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-115, AND MASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-115, AND MASSSPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-115, AND MASSSPECTROMETRY. | |
| "Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-115, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-115, AND MASSSPECTROMETRY. | |